WuXi Biologics (Cayman) Inc. (WXIBF)

WuXi Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,936	9,282	16,000	32,432	50,135	54,159
Market Cap Growth	-41.99%	-41.99%	-50.67%	-35.31%	-7.43%	230.33%
Enterprise Value	11,646	9,147	15,717	31,764	48,751	53,941
Last Close Price	2.74	2.17	3.71	7.15	12.14	12.57
PE Ratio	25.96	20.19	33.37	50.61	93.99	209.36
PS Ratio	4.67	3.63	6.66	14.65	30.95	63.00
PB Ratio	1.92	1.49	2.58	6.18	9.74	16.92
P/TBV Ratio	2.19	1.70	2.96	6.79	10.56	17.69
P/FCF Ratio	-	-	182.37	-	-	-
P/OCF Ratio	-	-	24.31	40.37	92.82	187.95
EV/Sales Ratio	4.55	3.58	6.54	14.35	30.10	62.75
EV/EBITDA Ratio	15.21	11.96	22.61	43.22	85.50	198.82
EV/EBIT Ratio	18.51	14.56	28.34	50.36	97.69	234.41
EV/FCF Ratio	-	-	179.13	-	-	-
Debt / Equity Ratio	0.11	0.11	0.10	0.12	0.13	0.16
Debt / EBITDA Ratio	0.89	0.89	0.89	0.86	1.18	1.85
Debt / FCF Ratio	-	-	7.33	-	-	-
Asset Turnover	0.33	0.33	0.32	0.33	0.28	0.24
Inventory Turnover	6.71	6.71	5.04	4.31	3.94	4.15
Quick Ratio	1.98	1.98	2.35	1.56	1.85	2.49
Current Ratio	2.73	2.73	2.78	1.98	2.37	3.16
Return on Equity (ROE)	8.82%	8.82%	8.90%	13.20%	13.09%	10.02%
Return on Assets (ROA)	5.05%	5.05%	4.63%	5.81%	5.43%	4.03%
Return on Capital (ROIC)	5.79%	5.79%	5.51%	7.00%	6.47%	4.78%
Return on Capital Employed (ROCE)	9.50%	9.50%	8.00%	10.80%	8.90%	6.10%
Earnings Yield	3.85%	4.95%	3.00%	1.98%	1.06%	0.48%
FCF Yield	-	-	0.55%	-0.15%	-0.97%	-1.17%
Buyback Yield / Dilution	2.80%	2.80%	0.62%	1.04%	-5.05%	-5.30%

Updated Sep 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.